Capital Change Notice - Issue of ordinary shares

14 April 2021

Issue of ordinary shares

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in AFT Pharmaceuticals Limited under the AFT Pharmaceuticals Limited Long Term Incentive Plan.

Section 1: Issuer information
Name of issuer AFT Pharmaceuticals Limited
NZX ticker code AFT
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZAFTE0001S4
Currency NZD
Section 2: Capital change details
Number issued 60,000
Nominal value (if any) Not applicable
Issue price per security $2.80
Nature of the payment Not applicable
Amount paid up (if not in full) In full
Percentage of total class of Financial Products issued (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 0.057%
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue and specific authority for issue 60,000 shares were issued to an employee exercising options under the AFT Pharmaceuticals Limited Long Term Incentive Plan
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. 104,643,875
Specific authority for the issue, including a reference to the rule pursuant to which the issue is made Directors’ resolution, Listing Rule 4.6
Terms or details of the issue (for example: restrictions, escrow arrangements) The ordinary shares issued rank pari passu with the existing ordinary shares
Date of issue 13 April 2021
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Malcolm Tubby
Contact person for this announcement Malcolm Tubby
Contact phone number +64 9 488 0232
Contact email address [email protected]
Date of release through MAP 14 April 2021

---

Announcement PDF